Published by Bupa's health information team, February 2008.
This factsheet is for people with liver cancer or who would like information about it.
Cancer that starts in the liver (primary liver cancer) is rare in the UK. About 2,500 people each year are diagnosed with it and approximately twice as many men as women are affected. Cancers which spread to the liver (secondary liver cancer) are much more common. These occur when a cancer starts elsewhere in your body, such as your bowel, breast or lungs, and spreads to your liver.
A Flash plug-in is required to view this animation.
Legal notices
The liver is a large organ found in the top part of your abdomen (tummy), just under your rib cage. It's split into sections called lobes.
Your liver carries out about 500 different jobs, including:
In addition, it can repair itself and still function when much of it is damaged.
The liver and surrounding structures
A liver tumour is a lump created by an abnormal and uncontrolled growth of cells. It can either be malignant (cancerous) or benign. Most tumours in the liver are benign. Benign tumours are not cancerous. They don't spread to other parts of the body and don't invade surrounding tissue.
Cancerous tumours can grow through your liver and spread to other parts of your body (through the bloodstream or the lymph system) where they may grow and form secondary tumours. This spread of cancer is called a metastasis. Tumours may spread to the liver from other parts of the body - this is secondary liver cancer.
There are two main types of primary liver cancer - hepatocellular carcinoma and cholangiocarcinoma. Hepatocellular carcinoma (also known as hepatoma or HCC) is the most common type of liver cancer. It starts in the main cells of the liver called hepatocytes.
Cholangiocarcinoma starts in the cells that line your bile duct. The bile duct is a tube that connects your liver to your small bowel.
There are some other, much rarer types of liver cancer including:
Everyone with liver cancer will be affected differently but it's quite likely that at first you won't have any symptoms. Later on you may have symptoms including:
Although not necessarily a result of liver cancer, if you have these symptoms you should visit your GP.
There are a number of things that mean you may be more at risk of developing hepatocellular carcinoma. These include the following.
The exact reasons why you may develop cholangiocarcinoma are not fully understood at present. However, if you have an inflammatory bowel condition such as ulcerative colitis you may be slightly more at risk.
Your GP will ask about your symptoms and examine you. He or she may also ask you about your medical history and possibly take a blood sample. Your GP may refer you to a specialist at a hospital where you are likely to have tests, including liver function tests. These check that your liver is working properly by looking at a sample of your blood. Some of the other tests your doctor may recommend include the following.
This will depend on how advanced your cancer is and also on your general state of health. Treatment will also vary according to where exactly the cancer is and whether or not it has spread to other parts of your body. All treatments can cause side-effects and it's important to talk to your doctor to get information and advice before going ahead with anything.
If you have secondary liver cancer, your treatment will depend on where the primary cancer has spread from.
This is the best treatment for liver cancer and the only one that offers a possible cure. However, it's likely that you won't be able to have surgery because your cancer is too big or has spread elsewhere in your body. Fewer than one in three people who have hepatocellular carcinoma can have surgery to remove it.
There are a number of different types of surgery that can be used to treat liver cancer.
As much as 80 percent of your liver may be taken away if you have a liver resection or lobectomy. However, your liver is able to repair itself and can grow back to its original size within a few weeks.
If your cancer is small, you may be able to have it treated with injections of ethanol. Ethanol is an alcoholic liquid that destroys the cancer cells. In this procedure, it's injected through your skin straight into the affected area of your liver. The number of sessions you need will depend on whether you have more than one tumour and how big they are. In each session you may have one or two injections.
This treatment uses heat from radiowaves to kill cancer cells. A thin needle is placed in the tumour and then radiowaves are passed down it - these heat up the tumour and destroy it.
Chemotherapy involves using medicines (usually given by injection into a vein or artery) such as doxorubicin which kill cancer cells. This treatment aims to shrink your cancer and reduce the symptoms it causes. Chemotherapy isn't very successful for treating liver cancer, but a procedure called chemoembolisation may be more effective. The chemotherapy medicines are mixed with an oily substance called lipiodol that helps them to stay in the liver for longer and so have a greater effect. At the same time, tiny beads of gel are injected to block off the blood supply to the tumour - without this the tumour can't survive.
This isn't usually used to treat hepatocellular carcinomas but may be a possibility if you have cholangiocarcinoma. It uses X-rays to kill cancer cells but can cause damage to healthy liver cells. It's occasionally given in combination with chemotherapy.
Bupa offers Bupa Liver Health, an advanced liver assessment that can detect early signs of liver problems and disease, with advice to manage risks.
This information was published by Bupa's health information team and is based on reputable sources of medical evidence. It has been peer reviewed by Bupa doctors. The content is intended for general information only and does not replace the need for personal advice from a qualified health professional.
Publication date: February 2008.
Have you found the information in this factsheet helpful? Do take a couple of moments to give us your feedback.